baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

International Stem Cell Corp./ US4603782016 /

6/4/2024 9:46:33 PM	Chg. -0.0189	Volume	Bid-	Ask-	High	Low
0.0901USD	-17.34%	4,477 Turnover: 390.4634	-Bid Size: -	-Ask Size: -	0.0901	0.0900

GlobeNewswire 1/31/2022 Team One Names Latest Recipient Of The Legacy Lab Foundation Scholarship

GlobeNewswire 12/17/2021 Heading Into 2022, Team One Doubles Down On Talent Management & Employee Growth With Two Senior Prom...

GlobeNewswire 11/18/2021 Small Pharma Strengthens Board With Appointment of Paul Maier as Independent Director

GlobeNewswire 10/12/2021 Team One Receives Top Honors at Adweek’s Media Plan of the Year Awards for its Lexus “All In” Campai...

GlobeNewswire 10/4/2021 Team One Announces Third Annual Legacy Lab Foundation Scholarship Call For Submissions

GlobeNewswire 8/9/2021 Team One Named to Fast Company’s “Best Workplaces for Innovators” List

GlobeNewswire 8/5/2021 Team One Rounds Out Leadership Team with First-Ever Chief Data Officer, Prachi Priya

GlobeNewswire 4/1/2021 Final Results for the year ended 31 December 2020

GlobeNewswire 2/18/2020 BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 20...

GlobeNewswire 11/14/2019 BrainStorm Announces Financial Results for the Third Quarter of 2019 and Provides a Corporate Update

GlobeNewswire 11/12/2019 BrainStorm Cell Therapeutics Announces Ralph Kern MD MHSc to Present at the 7th International Stem C...

GlobeNewswire 8/15/2019 Global Stem Cell & Regenerative Therapy Market 2018-2024: A Research Outlook

GlobeNewswire 7/2/2019 Global $25.4 Bn Tissue Engineering (Technologies and Therapeutic) Markets, 2015-2018 & 2019-2024: Or...

GlobeNewswire 5/17/2019 International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2019

GlobeNewswire 5/8/2019 International Stem Cell Corporation is Valued at $43 Million Market Value by Edison Investment Resea...

GlobeNewswire 4/29/2019 International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson's Disease Clini...

GlobeNewswire 4/25/2019 Alpha- Antitrypsin Deficiency Pipeline Review, H1 2019 - Therapeutic Analysis of 19 Companies & Drug...

GlobeNewswire 4/15/2019 International Stem Cell Corporation Announces 2018 Fourth Quarter and Year-End Results

GlobeNewswire 4/5/2019 Crigler-Najjar Syndrome Pipeline Review, H1 2019 - Therapeutics Analysis Featuring Audentes Therapeu...

GlobeNewswire 3/14/2019 Neural Stem and Progenitor Cell Products: A Strategic Development Analysis Report, 2019

GlobeNewswire 3/4/2019 International Stem Cell Corporation Commences Trading on the OTCQX Best Market

GlobeNewswire 2/13/2019 International Stem Cell Corporation Publishes Successful Results in Traumatic Brain Injury

GlobeNewswire 1/15/2019 International Stem Cell Corporation Granted Key US Patent Protecting Anti-Aging Business

GlobeNewswire 12/4/2018 Edison issues update on International Stem Cell (ISCO)

GlobeNewswire 11/15/2018 International Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months...

International Stem Cell Corp./ US4603782016 /

If you wish to receive reply to your feedback, please provide your email address.